Business Information
The group's principal activity is to design and develop next-generation tools for the large-scale analysis of genetic variation and function. The group's patented bead array technology uses fiber optics to achieve a level of array miniaturization that allows for a new scale of experimentation. The tools provide information that could be used by life sciences and pharmaceutical companies to improve drugs and therapies, customize diagnoses and treatment and cure diseases. The group's complementary oligator technology permits parallel synthesis of the millions of different pieces of dna necessary to perform large-scale genetic analysis on arrays. Illumina(R) , arrays of arraystm, beadarraytm, goldengatetm and oligatortm are the group's trademarks. The group's technology has applicability across a wide variety of industries, including agriculture, petrochemicals and food and beverages.
|
|
Name |
Title
|
Email
|
| William Rastetter | Chmn. | N/A | | Christian Henry | CFO, VP | N/A | | John Stuelpnagel | Dir., Co - Founder, COO, Sr. VP | N/A | | Arthur Holden | Sr. VP - Corporate, Marketing Development | N/A | | Christian Cabou | Sr. VP, General Counsel | N/A |
|
|
Year |
Sales |
Net Income |
| 2006 | 184,586 | 39,968 | | 2005 | 50,583 | (6,225) | | 2006 | 73,501 | (20,874)
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
